Alume Biosciences is pioneering a proprietary nerve illumination technology designed to enhance surgical precision and patient outcomes. Their flagship compound, ALM-488, is a human nerve peptide developed through collaboration between Dr. Quyen Nguyen and Nobel Laureate Dr. Roger Tsien. This innovative peptide selectively targets human nerves, allowing them to glow during surgical procedures. By administering ALM-488 intravenously prior to surgery, surgeons can visualize critical nerves in real-time, significantly reducing the risk of nerve damage during operations, particularly in high-stakes areas such as head and neck surgeries.

The potential applications of this technology extend beyond its initial use, as it aims to improve the accuracy of surgical resections and reconstructive procedures. The ability to illuminate nerves could transform the surgical landscape, providing surgeons with enhanced capabilities to preserve nerve function and ultimately improve the quality of life for patients. With human clinical trials anticipated to begin, Alume Biosciences is positioned at the forefront of a significant advancement in surgical techniques, promising to mitigate the debilitating effects of nerve injuries that can occur during surgery.

United States

The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.

Alume Biosciences

Company Details